Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
A high-profile MEV attack on the jaredfromsubway.eth wallet coincides with Vitalik Buterin's push to curb these explo...
A legendary macro investor who warned about the 2008 bubble has sold Alphabet and moved into AI hardware names, signa...
An AI-driven crypto benchmark echoes a cautionary tale: even with time and resources, strategic missteps can trigger ...
Tesla breaches a key price level near $382 as investors weigh margin pressures from tech compression and intensifying...
DeXe shows resilience as on-chain activity climbs and wallet growth accelerates amid a broader market downturn. Analy...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...
Bitcoin ETFs just posted a third-worst week on record as large outflows weigh on BTC. The digital asset trades near $...
A landmark Supreme Court decision weakens protections for independent agencies, injecting uncertainty into the pace a...
Wes Moss outlines why waiting to convert to a Roth IRA may reduce tax bills for pre-retirees. With retirement tax rat...
As crypto sought to replace Wall Street, major institutions now drive crypto’s rails and settlement systems, reshapin...